Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 5
2016 5
2017 2
2018 3
2019 7
2020 5
2021 3
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, Hamada S, Iyama S, Saruwatari K, Saeki S, Takahashi M, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: saruwatari k. Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022. Oncoimmunology. 2022. PMID: 35655708 Free PMC article.
Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.
Tomita Y, Sakata S, Imamura K, Iyama S, Jodai T, Saruwatari K, Hamada S, Akaike K, Anai M, Fukusima K, Takaki A, Tsukamoto H, Goto Y, Motozono C, Sugata K, Satou Y, Ueno T, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: saruwatari k. Cancers (Basel). 2023 Dec 21;16(1):47. doi: 10.3390/cancers16010047. Cancers (Basel). 2023. PMID: 38201474 Free PMC article.
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis.
Anai M, Yoshida C, Ozono K, Furukawa H, Ishimaru Y, Sakata S, Saruwatari K, Muramoto K, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Anai M, et al. Among authors: saruwatari k. Allergol Int. 2022 Apr;71(2):259-261. doi: 10.1016/j.alit.2021.11.003. Epub 2022 Jan 21. Allergol Int. 2022. PMID: 35074267 Free article. No abstract available.
Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer.
Imamura K, Tomita Y, Sato R, Ikeda T, Iyama S, Jodai T, Takahashi M, Takaki A, Akaike K, Hamada S, Sakata S, Saruwatari K, Saeki S, Ikeda K, Suzuki M, Sakagami T. Imamura K, et al. Among authors: saruwatari k. Int J Mol Sci. 2022 Nov 8;23(22):13723. doi: 10.3390/ijms232213723. Int J Mol Sci. 2022. PMID: 36430217 Free PMC article.
Successful treatment with dupilumab for mucus plugs in severe asthma.
Anai M, Yoshida C, Izumi H, Muramoto K, Saruwatari K, Tomita Y, Ichiyasu H, Sakagami T. Anai M, et al. Among authors: saruwatari k. Respirol Case Rep. 2022 Dec 15;11(1):e01074. doi: 10.1002/rcr2.1074. eCollection 2023 Jan. Respirol Case Rep. 2022. PMID: 36540290 Free PMC article.
Clinical impact of SUVmax of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection.
Akaike K, Saruwatari K, Matsushima R, Fujino K, Morinaga J, Oda S, Takahashi H, Shiraishi S, Okabayashi H, Hamada S, Tomita Y, Masunaga A, Saeki S, Ikeda K, Ichiyasu H, Suzuki M, Sakagami T. Akaike K, et al. Among authors: saruwatari k. J Thorac Dis. 2022 Oct;14(10):3801-3810. doi: 10.21037/jtd-22-604. J Thorac Dis. 2022. PMID: 36389305 Free PMC article.
33 results